International audienceThe detection of pathological changes in neurodegenerative diseases that occur before clinical onset would be of great value for identifying suitable subjects and assessing drug ecacy in trials aimed at preventing or slowing onset. Using MRI derived volumetric information, researchers have been able to detect significant di↵erences between patients in the presymptomatic phase of neurodegenerative diseases and healthy controls. However, volumetric studies provide only a summary representation of complex morphological changes. Shape analysis has already been successfully applied to model pathological features in neu-rodegeneration and represents a valuable instrument to model presymp-tomatic anatomical changes occurring ...
AbstractThis paper uses diffeomorphometry methods to quantify the order in which statistically signi...
This paper uses diffeomorphometry methods to quantify the order in which statistically significant m...
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY licens...
International audienceThe detection of pathological changes in neurodegenerative diseases that occur...
Brain atrophy as measured from structural MR images, is one of the primary imaging biomarkers used t...
Brain atrophy as measured from structural MR images, is one of the primary imaging biomarkers used t...
Brain atrophy as measured from structural MR images, is one of the primary imaging biomarkers used t...
Supplementary tables and figure of paper Spatio-temporal analysis for detection of pre-symptomatic s...
We develop a multivariate analysis of brain anatomy to identify the relevant shape deformation patte...
AbstractThis paper uses diffeomorphometry methods to quantify the order in which statistically signi...
This paper uses diffeomorphometry methods to quantify the order in which statistically significant m...
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY licens...
International audienceThe detection of pathological changes in neurodegenerative diseases that occur...
Brain atrophy as measured from structural MR images, is one of the primary imaging biomarkers used t...
Brain atrophy as measured from structural MR images, is one of the primary imaging biomarkers used t...
Brain atrophy as measured from structural MR images, is one of the primary imaging biomarkers used t...
Supplementary tables and figure of paper Spatio-temporal analysis for detection of pre-symptomatic s...
We develop a multivariate analysis of brain anatomy to identify the relevant shape deformation patte...
AbstractThis paper uses diffeomorphometry methods to quantify the order in which statistically signi...
This paper uses diffeomorphometry methods to quantify the order in which statistically significant m...
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY licens...